A provider of micro surgical instruments
| Round | Amount | Announced | Lead | Verified | Status | Sources |
|---|---|---|---|---|---|---|
| Series C Series C | n/a | ~ 2026-09-22 | not stated | 1 | [ CHECK ] | 1 |
[ VERIFIED ]0.52 read against its primary page [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search: startup funding roundup this week raised Series C Series D g...·[ SCRAPE ]1 page read: bebeez.eu·[ JSON ]round extracted with a schema, grounded to one sentence·[ VERIFY ]confirmedread back against its page by Firecrawl·[ BRANDING ]homepage not matched·[ AGENT ]dossier built by the Firecrawl agent | ||||||
Medical Microinstruments (MMI) builds the Symani Surgical System, a robotic platform with wristed microinstruments that helps surgeons perform delicate open microsurgery and supermicrosurgery.
| Round | Amount | Announced | Lead |
|---|---|---|---|
| Seed financing | $2M | undated | Sambatech Angel Investors |
| Series A | €20M (approx. $24.5M) | 2018-04-18 | Andera Partners |
| Series B | $75M | 2022-07-20 | Deerfield Management, RA Capital |
| Series B extension | $12M | 2022 | Wellington Partners |
| Series C equity financing | $110M | 2024-02-21 | Fidelity Management & Research Company |
MMI is addressing a difficult open-surgery problem: its motion scaling, tremor reduction and very small wristed instruments are designed to help surgeons repair vessels, nerves and lymphatic structures that can be less than a millimeter in diameter, potentially expanding access to microsurgery. The company says its $110M Series C will fund commercialization, clinical evidence and indication expansion, while it projects eligible robotic microsurgical procedures could grow from 3 million to 22 million annually by 2028.
No homepage passed the identity check, so nothing was written. Refresh profile tries again with what the record now knows.